720 related articles for article (PubMed ID: 15626306)
1. [Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].
Meijnen P; Peterse JL; Nieweg OE; Rutgers EJ
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2428-32. PubMed ID: 15626306
[TBL] [Abstract][Full Text] [Related]
2. Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes.
van Rijk MC; Peterse JL; Nieweg OE; Oldenburg HS; Rutgers EJ; Kroon BB
Cancer; 2006 Aug; 107(3):467-71. PubMed ID: 16804924
[TBL] [Abstract][Full Text] [Related]
3. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impact.
Dabbs DJ; Fung M; Johnson R
Breast J; 2004; 10(3):190-4. PubMed ID: 15125743
[TBL] [Abstract][Full Text] [Related]
5. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of axillary sentinel lymph node 'micrometastases' in breast cancer.
Krauth JS; Charitansky H; Isaac S; Bobin JY
Eur J Surg Oncol; 2006 May; 32(4):400-4. PubMed ID: 16504456
[TBL] [Abstract][Full Text] [Related]
7. [Sentinel node biopsy in breast cancer--a minimally invasive procedure for staging of the axilla].
Haid A; Fritzsche H; Peschina W; Gruber-Mösenbacher U; Jasarevic S; Hillbrand E; Müller G; Köberle-Wührer R; Schmidle T; Breitfellner G
Wien Klin Wochenschr; 1999 Mar; 111(6):219-25. PubMed ID: 10234775
[TBL] [Abstract][Full Text] [Related]
8. Transcription-reverse transcription concerted reaction and minimal residual disease in axillary sentinel nodes of breast cancer.
Ishikawa T; Miyajima E; Sasaki T; Tanabe M; Matsumoto C; Nozawa A; Kawachi K; Fukuno Y; Takeda H; Hayashi T; Onaka S; Momiyama N; Ichikawa Y; Inui K; Shimada H
Eur J Surg Oncol; 2007 May; 33(4):430-4. PubMed ID: 17101257
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of axillary lymph node micrometastases in breast cancer.
Sakorafas GH; Geraghty J; Pavlakis G
Eur J Surg Oncol; 2004 Oct; 30(8):807-16. PubMed ID: 15336724
[TBL] [Abstract][Full Text] [Related]
10. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
11. [Sentinel lymph node biopsy with micrometastases in breast cancer: histological data and surgical implications. About a series of 201 axillary dissections after peroperative sentinel node identification].
Marin C; Mathelin C; Neuville A; Mertz L; Constantinesco A; Chenard MP; Bellocq JP
Bull Cancer; 2003 May; 90(5):459-65. PubMed ID: 12850769
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy in breast cancer patients: the medical oncology perspective.
Catzeddu T; Bertelli G; Del Mastro L; Venturini M
J Surg Oncol; 2004 Mar; 85(3):129-32. PubMed ID: 14991884
[TBL] [Abstract][Full Text] [Related]
13. [Very slight chance of other metastases in axillary nodes of breast cancer patients with a small sentinel node metastasis without extranodal tumor growth].
van der Loo EM; Hop WC; Tervoort MA; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(19):938-43. PubMed ID: 15160561
[TBL] [Abstract][Full Text] [Related]
14. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
[TBL] [Abstract][Full Text] [Related]
15. Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancer.
Gui GP; Joubert DJ; Reichert R; Ward A; Lakhani S; Osin P; Nerurkar A; A'Hern R; Benson K; Underwood SR
Eur J Surg Oncol; 2005 Sep; 31(7):707-14. PubMed ID: 15993028
[TBL] [Abstract][Full Text] [Related]
16. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
17. Three-axillary lymph node sampling for the prediction of nonsentinel node metastases in breast cancer patients with sentinel node metastases.
Motomura K; Egawa C; Komoike Y; Nagumo S; Koyama H; Inaji H
Ann Surg Oncol; 2006 Jul; 13(7):985-9. PubMed ID: 16788761
[TBL] [Abstract][Full Text] [Related]
18. [The role of the histopathological analysis of sentinel lymph nodes in breast cancer. Preliminary findings].
Cserni G; Boross G; Baltás B
Orv Hetil; 1998 Aug; 139(32):1899-903. PubMed ID: 9731445
[TBL] [Abstract][Full Text] [Related]
19. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS; van der Heiden-van der Loo M; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
[TBL] [Abstract][Full Text] [Related]
20. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]